Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 230,99
Anzahl: 3 verfügbar
In den WarenkorbZustand: New. pp. 448.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 271,21
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 1st edition. 448 pages. 9.30x6.30x1.20 inches. In Stock.
Anbieter: Kennys Bookstore, Olney, MD, USA
EUR 293,69
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. This book presents advances in the field of neuronal mitochondria functions, relation to therapeutics, and pharmacology. For scientists and researchers in both industry and academia, this book provides detailed discussion, examples, and approaches, to illustrate the potential of mitochondria as therapeutic targets for neuronal diseases. Editor(s): Gribkoff, Valentin K.; Jonas, Elizabeth A. Series: Wiley Series on Neuropharmacology. Num Pages: 448 pages, illustrations. BIC Classification: MJN; PSAN. Category: (P) Professional & Vocational. Dimension: 240 x 166 x 28. Weight in Grams: 778. . 2015. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland.
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Neuware - This book presents advances in the field of neuronal mitochondria - functions, relation to therapeutics, and pharmacology. For scientists and researchers in both industry and academia, this book provides detailed discussion, examples, and approaches, to illustrate the potential of mitochondria as therapeutic targets for neuronal diseases.\* Helps readers understand the regulation of mitochondrial cellular processes, such as substrate metabolism, energy production, and programmed versus sporadic cell death\* Offers insights on the development of strategies for targeted therapeutic approaches and potential personalized treatments\* Includes examples of mitochondrial drugs, development, and mitochondria-targeted approaches for more efficient treatment methods and further developments in the field\* Covers the model systems and approaches needed for the development of new drugs for the central nervous system to provide potential modern therapeutics for neurodegenerative disorders.